news_6

Takeda’s Maribavir Phase 3 Clinical Trial Met Primary Endpoint of Superiority to Conventional Antiviral Therapy in Transplant Recipients With Refractory, With or Without Resistance, Cytomegalovirus Infection/Disease

More Than Twice As Many Transplant Recipients With Refractory, With or Without Resistance (R/R), Cytomegalovirus (CMV) Infection/Disease Treated With Maribavir,...

news_6

Asia Pacific Virus Filtration Markets 2020-2026: Consumables, Instruments, Services – COVID-19 Impact and Growth Opportunity – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Virus Filtration Market 2020-2026 by Product (Consumables, Instruments, Services), Application, End User, and Country: COVID-19 Impact...

news_6

Jingsu Pu Rejoins MetLife Investment Management as Global Head of Insurance Strategy & Solutions and Head of Institutional Client Group, Asia Ex-Japan

Key hire enhances MetLife Investment Management’s global insurance asset management capabilities and expands its Institutional Client Group presence in Asia...